Search
Prelude Therapeutics Inc
PRLDAdd to Watchlist
4.600USD
-0.450-8.91%
Close 07-31 16:00（ET）Quotes delayed by 15 min
366.37MMarket Cap
LossP/E TTM
Prelude Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Prelude Therapeutics Inc is 5.99, ranking 349 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.62, which is -92.15% below the recent high of -0.36 and -15.87% above the recent low of -5.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.